Live Workshop: Cancer Food Confidence Feb 19, 20, 21

Calcium D-Glucarate: The Enzyme Blocker That Supports Hormonal Detox and Cancer Chemoprevention

By Keith Bishop | Clinical Nutritionist, Cancer Coach, Retired Pharmacist | Prevail Over Cancer

If your liver has already done the hard work of neutralizing a toxin or excess hormone — but your gut is quietly undoing all of that work before it can leave your body — you have an enzyme problem.

That enzyme is called beta-glucuronidase. And one of the most-researched natural compounds for addressing it is calcium D-glucarate.

In this post, we'll break down exactly what calcium D-glucarate is, how it works at the biochemical level, what the research shows across multiple cancer types, and where it fits inside a comprehensive integrative oncology protocol.

 

What Is Calcium D-Glucarate?

Calcium D-glucarate is the calcium salt of D-glucaric acid — a naturally occurring compound produced in small amounts by the human body and found abundantly in a variety of plant foods. The calcium is there for stability in supplement form. The active ingredient is the glucarate portion.

Glucaric a...

Continue Reading...

Astaxanthin and Cancer: The Science Behind Nature's Most Powerful Anticancer Carotenoid

A Peer-Reviewed Clinical Guide for Clinicians and Patients on Astaxanthin's Anticancer Mechanisms, Natural Sources, and Therapeutic Integration

Researched and written by Keith Bishop, Clinical Nutritionist, Cancer Coach, Integrative Cancer Educator, Retired Pharmacist, and Founder of Prevail Over Cancer and the Prevail Protocol.


Key Takeaways

  • Astaxanthin (ASX) is a keto-carotenoid derived primarily from the microalga Haematococcus pluvialis and marine seafood, with antioxidant potency up to 100 times greater than vitamin E.
  • Peer-reviewed research documents nine distinct anticancer mechanisms, including NF-ÎşB suppression, Nrf2 activation, induction of apoptosis, STAT3 inhibition, and anti-metastatic activity.
  • Preclinical evidence spans breast, colon, liver, prostate, lung, leukemia, melanoma, gastric, and oral cancers.
  • Emerging 2024–2025 research identifies new mechanisms, including modulation of the gut microbiota and targeting of the USP39/β-catenin pathway in hepatocellular
  • ...
Continue Reading...
Close

Get Free Access to Keith’s Sunday Tactics Newsletter.

Join thousands of subscribers!
Get new cancer tactics each week.